AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.

AstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to almost double ...

AstraZeneca Plc agreed to buy Icosavax Inc. for as much as $1.1 billion to gain a developer of innovative vaccines for respiratory viruses.

LONDON, March 17 (Reuters) - AstraZeneca Plc is considering cutting 120 jobs in Germany, or just over 9 percent of its staff in the country, the drugmaker's German unit said on Tuesday. The move ...

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

When the British-Swedish drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine is 70% effective on average, the world exhaled a collective sigh of relief and stocks ...

Johnson & Johnson — which, like AstraZeneca, had vowed to sell its vaccine at a not-for-profit price — expects $2.5 billion in revenue from its vaccine this year.

British pharmaceutical giant AstraZeneca Wednesday announced it will transition to “modest profitability” for sales of its Covid-19 vaccine, departing from previous commitments to sell the ...

AstraZeneca’s new clinical trial results are positive but confusing, leaving many experts wanting to see more data before passing final judgment on how well the vaccine will work.